or Try an Advanced Search...

    Applied Genetics Stocks List

    Symbol Grade Name % Change
    ME D 23andMe Holding Co. 2.26
    BOLD D Boundless Bio, Inc. 1.94
    FLGT F Fulgent Genetics, Inc. -0.79
    GBIO D Generation Bio Co. -5.07
    GENE F Genetic Technologies Ltd 0.84
    GNPX F Genprex, Inc. -5.13
    LXEO F Lexeo Therapeutics, Inc. 1.67
    NTRA A Natera, Inc. -0.06
    PSNL C Personalis, Inc. -0.63
    RGNX F REGENXBIO Inc. 0.53
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biotechnology Biology Medical Genetics Gene Therapy Cancer Genetic Testing Genetics Medical Test Medicine Molecular Biology Rare Diseases DNA DNA Paternity Testing Disease Emerging Technologies Gene Delivery Genomics Life Sciences Molecular Diagnostics Acid

    Related ETFs - A few ETFs which own one or more of the above listed Applied Genetics stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 10.25
    EKG C First Trust Nasdaq Lux Digital Health Solutions ETF 4.29
    FRTY C Alger Mid Cap 40 ETF 4.04
    HTEC D Robo Global Healthcare Technology and Innovation ETF 3.55
    ATFV C Alger 25 ETF 3.45
    View all Applied Genetics ETFs...
    Compare ETFs
    Compare GNOM to ATFV Compare GNOM to EKG Compare HTEC to ATFV

        Applied Genetics Stocks Recent News

        Date Stock Title
        May 7 LXEO Lexeo Therapeutics to Participate in Upcoming Investor Conferences
        May 6 FLGT Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 6 BOLD Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
        May 4 FLGT Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
        May 4 FLGT Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
        May 4 FLGT Q1 2024 Fulgent Genetics Inc Earnings Call
        May 3 FLGT Fulgent Genetics, Inc. (FLGT) Q1 2024 Earnings Call Transcript
        May 3 FLGT Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses
        May 3 FLGT Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
        May 3 NTRA New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer
        May 3 FLGT Fulgent Genetics reports mixed Q1 results; reaffirms FY24 outlook
        May 3 FLGT Fulgent Reports First Quarter 2024 Financial Results
        May 2 FLGT Fulgent Genetics Q1 2024 Earnings Preview
        May 2 NTRA Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
        May 2 NTRA Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
        May 1 NTRA Natera to Report its First Quarter 2024 Results on May 9
        May 1 RGNX REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights
        May 1 NTRA Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biotechnology Biology Medical Genetics Gene Therapy Cancer Genetic Testing Genetics Medical Test Medicine Molecular Biology Rare Diseases DNA DNA Paternity Testing Disease Emerging Technologies Gene Delivery Genomics Life Sciences Molecular Diagnostics Acid
        Applied Genetics

        Applied genetics is the application of genetic principles and techniques to the development of products and services that benefit society. This includes the use of genetic engineering to create new organisms, the use of genetic testing to diagnose and treat diseases, and the use of genetic information to develop new drugs and therapies. Applied genetics also includes the use of genetic information to improve crop yields, develop new animal breeds, and improve animal health.

        Browse All Tags